Explore the scientific frontier of identifying drugs that block SARS-CoV-2 entry, offering a powerful tool against current and future variants.
Discover how O-tert-butyl-threonine modification creates potent SARS-CoV-2 main protease inhibitors with enhanced cellular potency and antiviral effectiveness.